title: An in vitro assessment of aerosol delivery through patient breathing circuits used with medical air or a helium-oxygen mixture.
abstract: BACKGROUND
  The bench experiments presented herein were conducted in order to investigate the influence of carrier gas, either medical air or a helium-oxygen mixture (78% He, 22% O2), on the droplet size distribution and aerosol mass delivered from a vibrating mesh nebulizer through a patient breathing circuit.
  
  
  METHODS
  Droplet size distributions at the exit of the nebulizer T-piece and at the patient end of the breathing circuit were determined by laser diffraction. Additional experiments were performed to determine the effects on measured size distributions of gas humidity and of the droplet residence time during transport from the nebulizer to the laser diffraction measurement volume. Aerosol deposition in the nebulizer, breathing circuit, and on expiratory and patient filters was determined by photometry following nebulization of sodium fluoride solutions into the breathing circuit during simulated patient breathing.
  
  
  RESULTS
  With no humidification of the carrier gas, droplet volume median diameter (VMD) at the exit of the nebulizer T-piece was 5.5±0.1 μm for medical air, and 4.3±0.1 μm for helium-oxygen. Varying the aerosol residence time between the nebulizer and the measurement volume did not affect the measured size distributions; however, humidification of the carrier gases reduced differences in VMD at the nebulizer exit between medical air and helium-oxygen. At the patient end of the breathing circuit, droplet VMDs were 1.8±0.1 μm for medical air and 2.2±0.1 μm for helium-oxygen. The percentages of sodium fluoride recovered from the nebulizer, breathing circuit, patient filter, and expiratory filter were, respectively, 29.9±8.3, 40.4±5.6, 8.3±1.5, and 21.5±2.1% for air, and 32.6±2.2, 36.3±0.7, 12.0±1.4, and 19.1±1.1% for helium-oxygen.
  
  
  CONCLUSIONS
  Ventilation with helium-oxygen in place of air-oxygen mixtures can influence both the droplet size distribution and mass of nebulized aerosol delivered through patient breathing circuits. Assessment of these effects on aerosol delivery is important when incorporating helium-oxygen into patient ventilation strategies.
authors.affiliation: Medical Gases Group, Air Liquide Santé International, Centre de Recherche Claude-Delorme, Jouy-en-Josas, France. andrew-r.martin@airliquide.com
authors.forename: Andrew R
authors.initials: AR
authors.lastname: Martin
authors.forename: Angela
authors.initials: A
authors.lastname: Ang
authors.forename: Ira M
authors.initials: IM
authors.lastname: Katz
authors.forename: Sabine
authors.initials: S
authors.lastname: Häussermann
authors.forename: Georges
authors.initials: G
authors.lastname: Caillibotte
authors.forename: Joëlle
authors.initials: J
authors.lastname: Texereau
mesh_terms: D000336:Aerosols / Q000008:administration & dosage; D006371:Helium / Q000008:administration & dosage; D006801:Humans; D009330:Nebulizers and Vaporizers; D010100:Oxygen / Q000008:administration & dosage; D010316:Particle Size
chemical_list: D000336:Aerosols; D006371:Helium; D010100:Oxygen